The New Era of Postoperative Inflammation Management - Summary - MDSpire
Feature

The New Era of Postoperative Inflammation Management

What surgeons need to know about managing post-cataract inflammation

Share

Effective management of post-cataract inflammation is essential for optimizing patient recovery. Corticosteroids serve as powerful anti-inflammatory agents, while NSAIDs complement their effects. Traditional topical medications often lead to poor adherence, presenting challenges in postoperative care. Innovative strategies, such as intraoperative delivery systems like dexamethasone inserts, greatly reduce patient burden by ensuring sustained-release medication is available. This approach is particularly beneficial for glaucoma patients who need to manage inflammation and minimize additional drop usage, enhancing their overall recovery experience.

Original Source(s)

The New Era of Postoperative Inflammation Management

  • by Nandini Venkateswaran (1)

  • April 30, 2026

Related Content

Japan Debuts Novel Dry Eye Therapy

Senju Pharmaceutical launches the first TRPV1 antagonist for dry eye in Japan

  • April 30, 2026

  • 3 min
Why Smart Eye Surgeons Still Make Bad Growth Decisions

You’re not making poor decisions; you’re being forced to decide without clear, trustworthy data across your patient journey

Optogenetic RP Therapy Gains RMAT

Ray Therapeutics secures FDA RMAT designation for its optogenetic retinitis pigmentosa therapy

  • April 29, 2026

  • 2 min